logo
add image

Pfizer beats quarterly estimates despite Covid product decline, reaffirms modest outlook - CNBC

Feb. 4, 2026, 12:14 p.m.
Blog single photo

Pfizer on Tuesday reported fourth-quarter results that topped estimates even amid dwindling demand for its Covid products, while reaffirming its modest 2026 guidance that rattled investors in Decembe… [+2938 chars]

Leave Comments

Top